Novartis, Pfizer Advance Their NASH Ambitions Separately, As Partners

 
• By Joseph Haas
  
Liver Meeting Update, Boston 2019
Pfizer, Novartis are working to launching a Phase II NASH combo study in 2020
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business